12-Lipoxygenase and Ischemic Brain Cell Death
12-脂氧合酶和缺血性脑细胞死亡
基本信息
- 批准号:7404413
- 负责人:
- 金额:$ 33.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:12-HETE12-HPETEAddressArachidonate 12-LipoxygenaseAttentionBehavioralBlood - brain barrier anatomyBrainBrain EdemaBrain InjuriesBrain regionCaspaseCell DeathCell FractionationCell LineCell SurvivalCellsCerebral IschemiaCessation of lifeComplementContralateralCultured CellsDataEnzymesExtravasationFamilyFunctional disorderGenerationsGeneticGlutamatesHippocampus (Brain)HypoxiaImmunofluorescence ImmunologicImmunohistochemistryIn Situ Nick-End LabelingInfarctionInjuryIschemiaIschemic Brain InjuryKnock-outKnockout MiceKnowledgeLOX geneLipid PeroxidesLipidsLipoxygenaseMeasuresMediatingMediator of activation proteinMembraneMembrane LipidsMitochondriaModelingMusNeuronsOrganellesOther FindingOutcomeOxidative StressPTGS2 genePhospholipasePhysiological reperfusionPolyunsaturated Fatty AcidsProstaglandin-Endoperoxide SynthaseProtein IsoformsProtein-Lysine 6-OxidaseProteinsRattusReactive Nitrogen SpeciesReactive Oxygen SpeciesReperfusion TherapyResearch PersonnelResistanceSamplingSideSpecificityStaining methodStainsStrokeTechniquesTestingTimeTissue SampleToxic effectUp-RegulationWestern BlottingWild Type Mousebaicaleinbrain cellcell cortexcyclooxygenase 1cyclooxygenase 2cytotoxicityimprovedin vivoinhibitor/antagonistmembermouse modelmulticatalytic endopeptidase complexneuron lossnovelnovel therapeuticsprogramsresearch studysizetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Lipoxygenases and cyclooxygenases are among the oxidative enzymes that contribute to the generation of reactive oxygen species (ROS) after stroke. While the cyclooxygenases COX-1 and COX-2 have been and are continuing to be extensively studied, little data is available on the contribution of lipoxygenases to ischemic brain cell death. Our preliminary results have shown that levels of 12-LOX, the major lipoxygenase isoform in mouse and rat brain, are elevated in a mouse model of focal ischemia, predominantly in neuronal cells of the cortex. 12-LOX knockout mice show significantly reduced infarction sizes, a finding that seems to be mimicked by treatment of wild-type mice with a 12-LOX inhibitor. In both rat primary neurons and a murine hippocampal cell line, we have confirmed and extended the findings of others that 12-LOX mediates oxidative stress-induced cell death, and neurons prepared from the 12-LOX knockout mice show enhanced resistance to this form of oxidative stress. We thus propose the following Specific Aims: 1. To investigate 12-LOX upregulation and changes in activity in mouse brain after ischemia with various times of reoxyenation and to correlate increased 12-LOX levels with the extent of brain damage; 2. To study the mechanisms by which 12-LOX contributes to the death of cultured neuronal cells, and to elucidate the degradative machinery responsible for executing cell death downstream of 12-LOX action; 3. To determine the consequences of inactivating 12-LOX by either genetic or pharmacological means on brain damage after focal ischemia in the mouse. With the knowledge gained from these studies we seek to establish 12-LOX as a novel therapeutic target in the treatment of stroke.
描述(由申请人提供):脂氧合酶和环加氧酶属于氧化酶,有助于中风后产生活性氧(ROS)。虽然环加氧酶 COX-1 和 COX-2 已经并将继续得到广泛研究,但关于脂加氧酶对缺血性脑细胞死亡的贡献的数据很少。我们的初步结果表明,在局部缺血的小鼠模型中,12-LOX(小鼠和大鼠大脑中的主要脂氧合酶亚型)的水平升高,主要是在皮质神经元细胞中。 12-LOX 基因敲除小鼠的梗塞面积显着减小,这一发现似乎与用 12-LOX 抑制剂治疗野生型小鼠类似。在大鼠原代神经元和鼠海马细胞系中,我们已经证实并扩展了其他人的发现,即 12-LOX 介导氧化应激诱导的细胞死亡,并且从 12-LOX 敲除小鼠制备的神经元显示出对这种形式的增强的抵抗力。氧化应激。因此,我们提出以下具体目标: 1. 研究缺血后不同时间再氧合的小鼠大脑中 12-LOX 的上调和活性变化,并将 12-LOX 水平升高与脑损伤程度相关联; 2. 研究12-LOX导致培养神经元细胞死亡的机制,并阐明12-LOX作用下游执行细胞死亡的降解机制; 3. 确定通过遗传或药理学手段灭活 12-LOX 对小鼠局灶性缺血后脑损伤的影响。凭借从这些研究中获得的知识,我们寻求将 12-LOX 确立为治疗中风的新治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KLAUS VAN LEYEN其他文献
KLAUS VAN LEYEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KLAUS VAN LEYEN', 18)}}的其他基金
Testing the Lipoxygenase Inhibitor BPN-27332 as Acute Phase Stroke Treatment in the SPAN Network
在 SPAN 网络中测试脂氧合酶抑制剂 BPN-27332 作为急性期中风治疗的作用
- 批准号:
10671991 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
A Novel Neuroprotectant to Reduce Ischemic Injury
一种减少缺血性损伤的新型神经保护剂
- 批准号:
10576568 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
Development of human 12/15-lipoxygenase therapeutics for stroke
开发人类 12/15-脂氧合酶治疗中风的药物
- 批准号:
9922389 - 财政年份:2018
- 资助金额:
$ 33.55万 - 项目类别:
Development of human 12/15-lipoxygenase therapeutics for stroke
开发人类 12/15-脂氧合酶治疗中风的药物
- 批准号:
9898504 - 财政年份:2018
- 资助金额:
$ 33.55万 - 项目类别:
Novel 12/15 lipoxygenase inhibitors for the treatment of stroke
用于治疗中风的新型 12/15 脂氧合酶抑制剂
- 批准号:
8684486 - 财政年份:2014
- 资助金额:
$ 33.55万 - 项目类别:
Novel 12/15 lipoxygenase inhibitors for the treatment of stroke
用于治疗中风的新型 12/15 脂氧合酶抑制剂
- 批准号:
8846695 - 财政年份:2014
- 资助金额:
$ 33.55万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8305479 - 财政年份:2011
- 资助金额:
$ 33.55万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8041869 - 财政年份:2011
- 资助金额:
$ 33.55万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8470260 - 财政年份:2011
- 资助金额:
$ 33.55万 - 项目类别:
12/15-Lipoxygenase and neurovascular damage following cardiac arrest
心脏骤停后的 12/15-脂氧合酶和神经血管损伤
- 批准号:
8660352 - 财政年份:2005
- 资助金额:
$ 33.55万 - 项目类别:
相似海外基金
12(S)-HpETE/TRPV1 interaction mediates hyperglycemia-induced endothelial dysfunction: Novel approaches to early diagnosis and therapy of vascular pathology in diabetes mellitus
12(S)-HpETE/TRPV1 相互作用介导高血糖诱导的内皮功能障碍:糖尿病血管病理早期诊断和治疗的新方法
- 批准号:
390645560 - 财政年份:2018
- 资助金额:
$ 33.55万 - 项目类别:
Research Grants
Vitamin E Neuroprotection: Novel Molecular Mechanisms
维生素 E 神经保护:新颖的分子机制
- 批准号:
7382693 - 财政年份:2008
- 资助金额:
$ 33.55万 - 项目类别:
12/15-Lipoxygenase and Diabetic Neuropathy
12/15-脂氧合酶和糖尿病神经病变
- 批准号:
7314920 - 财政年份:2007
- 资助金额:
$ 33.55万 - 项目类别:
12/15-Lipoxygenase and Diabetic Neuropathy
12/15-脂氧合酶和糖尿病神经病变
- 批准号:
7467273 - 财政年份:2007
- 资助金额:
$ 33.55万 - 项目类别:
Participation of Arachiclonic Acid Lipoxygenase Products in the Pathogenesis of Cerebral Vasospasm After SAH.
花生四烯酸脂氧合酶产物参与 SAH 后脑血管痉挛的发病机制。
- 批准号:
01570813 - 财政年份:1989
- 资助金额:
$ 33.55万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)